Trademark Attorney / Law Firm
Jordan Marshall Greene – Trademark Portfolio
Jordan Marshall Greene specializes in Class 10 (Medical Apparatus) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 4 total filings concentrated in this category. The practice also covers Class 41 (Education & Entertainment) along with 4 other Nice Classification classes. Filing activity spans from 2024 to 2025. Currently, 1 trademark is registered and 1 is pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Jordan Marshall Greene's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has Jordan Marshall Greene filed?
Jordan Marshall Greene has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 pending, 2 abandoned.
What trademark classes does Jordan Marshall Greene specialize in?
Jordan Marshall Greene has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
How long has Jordan Marshall Greene been filing trademarks?
Jordan Marshall Greene's trademark filing history with the USPTO spans from 2024 to 2025, covering 1 year of trademark practice. During this period, Jordan Marshall Greene has handled 4 trademark applications.
What is Jordan Marshall Greene's trademark registration success rate?
Jordan Marshall Greene has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.